Viemed Healthcare (VMD)
(Real Time Quote from BATS)
$6.31 USD
+0.01 (0.16%)
Updated Jul 10, 2024 10:26 AM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
VMD 6.31 +0.01(0.16%)
Will VMD be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for VMD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for VMD
Viemed Healthcare, Inc. (VMD) Misses Q1 Earnings Estimates
Pediatrix (MD) Down 4.2% Despite Q1 Earnings & Revenue Beat
VMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
BellRing Brands Inc. (BRBR) Hit a 52 Week High, Can the Run Continue?
LeMaitre Vascular (LMAT) Q1 Earnings and Revenues Beat Estimates
Viemed Healthcare, Inc. (VMD) is on the Move, Here's Why the Trend Could be Sustainable
Other News for VMD
Viemed Healthcare Shareholders Approve Directors and Incentive Plan
Lake Street Remains a Buy on Viemed Healthcare (VMD)
Viemed Healthcare management to meet virtually with Lake Street
Viemed Healthcare management to meet virtually with Lake Street
Viemed Healthcare Engages Stakeholders with Investor Deck